UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000056654 |
|---|---|
| Receipt number | R000064463 |
| Scientific Title | Influence of the medical care system in a hematology ward on patient quality of life and anxiety |
| Date of disclosure of the study information | 2025/01/14 |
| Last modified on | 2025/01/07 21:32:56 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Influence of the medical care system in a hematology ward on patient quality of life and anxiety
Acronym
Influence of the medical care system in a hematology ward on patient quality of life and anxiety
Scientific Title
Influence of the medical care system in a hematology ward on patient quality of life and anxiety
Scientific Title:Acronym
Influence of the medical care system in a hematology ward on patient quality of life and anxiety
Region
| Japan |
Condition
Condition
hematology
Classification by specialty
| Hematology and clinical oncology |
Classification by malignancy
Malignancy
Genomic information
NO
Objectives
Narrative objectives1
Investigation of factors affecting patient quality of life and anxiety
Basic objectives2
Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
quality of life and anxiety
Key secondary outcomes
cost effectiveness
Base
Study type
Observational
Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 18 | years-old | <= |
Age-upper limit
| Not applicable |
Gender
Male and Female
Key inclusion criteria
Patients admitted to the hematology ward and starting chemotherapy during the study period.
Patients who are able to answer the questionnaire survey.
Patients who can give consent to participate in this study.
Key exclusion criteria
Patients under 18 years old.
Patients who are unable to respond to the questionnaire.
Patients whom the investigator determines are not appropriate to participate in the study.
Target sample size
200
Research contact person
Name of lead principal investigator
| 1st name | Masahiro |
| Middle name | |
| Last name | Yasuda |
Organization
Gifu Municipal Hospital
Division name
Department of Pharmacy
Zip code
500-8513
Address
7-1 kashima-cho, Gifu-shi, Gifu, Japan
TEL
+81-58-251-1101
m.yasuda@gmhosp.gifu.gifu.jp
Public contact
Name of contact person
| 1st name | Kazuhide |
| Middle name | |
| Last name | Tanaka |
Organization
Gifu Municipal Hospital
Division name
Department of Pharmacy
Zip code
500-8513
Address
7-1 kashima-cho, Gifu-shi, Gifu, Japan
TEL
+81-58-251-1101
Homepage URL
k-tanaka@gmhosp.gifu.gifu.jp
Sponsor or person
Institute
Gifu Municipal Hospital
Institute
Department
Personal name
Funding Source
Organization
Gifu Municipal Hospital
Organization
Division
Category of Funding Organization
Local Government
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Gifu Municipal Hospital Clinical Research Review Board
Address
7-1 kashima-cho, Gifu-shi, Gifu, Japan
Tel
+81-58-251-1101
kenkyu@gmhosp.gifu.gifu.jp
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2025 | Year | 01 | Month | 14 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Preinitiation
Date of protocol fixation
| 2024 | Year | 12 | Month | 23 | Day |
Date of IRB
Anticipated trial start date
| 2025 | Year | 01 | Month | 14 | Day |
Last follow-up date
| 2026 | Year | 01 | Month | 13 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
Nothing
Management information
Registered date
| 2025 | Year | 01 | Month | 07 | Day |
Last modified on
| 2025 | Year | 01 | Month | 07 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000064463
